In lung cancer tissue, PLOD2 has been shown to hydroxylate telopeptidyl lysine residues on collagen, which indirectly reduces the levels of lysine aldehyde–derived collagen cross-links [14]. Here, PLOD2 is linked to lung carcinoma.